2021 Veterinary Antimicrobial Sales Highlights Report

Working towards the preservation of effective antimicrobials for humans and animals

What's new

The Canadian Integrated Program for Antimicrobial Resistance Surveillance has launched interactive data which includes findings from the Veterinary Antimicrobial Sales Reporting system.


  • The Veterinary Antimicrobial Sales Reporting (VASR) data provide a comprehensive picture of medically important antimicrobials available for veterinary use and support our overall antimicrobial resistance surveillance program and stewardship.
  • Antimicrobials have been grouped according to their importance to human medicine and the report reflects our integration, analysis and interpretation of submitted data.
  • Sales of antimicrobials may not reflect patterns of antimicrobial use and data in this report, where possible, should be considered along with end-user information.
  • As there was improved provincial reporting of sales data after 2018, this should be taken into consideration when comparing sales data across years.
  • Unless otherwise noted, this report describes sales by manufacturers and importers, and excludes compounders, to avoid double counting of sales.

Key findings

In 2021, which is the fourth year of mandatory sales reporting, the key findings were:

Information on antimicrobials of importance to human medicine sold for use in animals

Animal species information

Information on route of administration

Regional information

Page details

Date modified: